Yanan Bie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yanan Bie has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hao Zhang
Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China
1 shared publication Hong Chang
Department of Traumatic Orthopedics, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510000, Guangdong, China
1 shared publication- Lin Zhou
School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China
1 shared publication - Ming Li
School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China
1 shared publication - Qinghua Tang
School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China
1 shared publication Weichao Hao
Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 8 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7109
Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway
Di-(2-ethylhexyl) phthalate (DEHP), a ubiquitous environmental plasticizer, has been increasingly linked to the exacerbation of inflammatory skin conditions, especially psoriasis. However, the mechanisms and effective therapeutic strategies targeting DEHP-aggravated psoriasis remain elusive. We integrated network toxicology, network pharmacology, and molecular docking to explore the targets of DEHP-exacerbated psoriasis and the protective effects of shikonin (SH). These findings were validated in a DEHP/IMQ-induced mouse model using a novel shikonin nanoparticle (SH-NP) that overcomes SH’s inherent hydrophobicity. Computational analyses revealed that SH counteracts DEHP skin toxicity through a multi-target network, identifying the p38 mitogen-activated protein kinase (p38 MAPK), TNF, IL-1β, proliferating cell nuclear antigen (PCNA), and matrix metalloproteinases 2 and 9 (MMP2/9) as core therapeutic nodes. Molecular docking verified this network, revealing robust binding between SH and key targets with binding energies ranging from −6.0 to −7.8 kcal/mol, consistently outperforming DEHP. In vivo experiments demonstrated that topical application of SH-NP significantly ameliorated macroscopic skin injury and reduced PASI scores. Mechanistically, SH-NP effectively reversed the DEHP-exacerbated inflammatory microenvironment by decreasing macrophage and mast cell infiltration in the dermis, reducing pro-inflammatory cytokine levels, and inhibiting the phosphorylation of p38 MAPK. Furthermore, SH-NP treatment successfully suppressed keratinocyte hyperproliferation, as evidenced by downregulated PCNA expression and reduced epidermal thickness. SH-NPs also markedly downregulated the elevated levels of MMP2/9 in mice, thereby mitigating collagen degradation and maintaining dermal matrix integrity. This study shows that SH-NPs alleviate DEHP-aggravated psoriasis by suppressing local inflammation, keratinocyte hyperproliferation, and collagen degradation, offering a targeted nanostrategy for environmentally exacerbated skin diseases.
- 8 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7109
Open AccessShikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway
Di-(2-ethylhexyl) phthalate (DEHP), a ubiquitous environmental plasticizer, has been increasingly linked to the exacerbation of inflammatory skin conditions, especially psoriasis. However, the mechanisms and effective therapeutic strategies targeting DEHP-aggravated psoriasis remain elusive. We integrated network toxicology, network pharmacology, and molecular docking to explore the targets of DEHP-exacerbated psoriasis and the protective effects of shikonin (SH). These findings were validated in a DEHP/IMQ-induced mouse model using a novel shikonin nanoparticle (SH-NP) that overcomes SH’s inherent hydrophobicity. Computational analyses revealed that SH counteracts DEHP skin toxicity through a multi-target network, identifying the p38 mitogen-activated protein kinase (p38 MAPK), TNF, IL-1β, proliferating cell nuclear antigen (PCNA), and matrix metalloproteinases 2 and 9 (MMP2/9) as core therapeutic nodes. Molecular docking verified this network, revealing robust binding between SH and key targets with binding energies ranging from −6.0 to −7.8 kcal/mol, consistently outperforming DEHP. In vivo experiments demonstrated that topical application of SH-NP significantly ameliorated macroscopic skin injury and reduced PASI scores. Mechanistically, SH-NP effectively reversed the DEHP-exacerbated inflammatory microenvironment by decreasing macrophage and mast cell infiltration in the dermis, reducing pro-inflammatory cytokine levels, and inhibiting the phosphorylation of p38 MAPK. Furthermore, SH-NP treatment successfully suppressed keratinocyte hyperproliferation, as evidenced by downregulated PCNA expression and reduced epidermal thickness. SH-NPs also markedly downregulated the elevated levels of MMP2/9 in mice, thereby mitigating collagen degradation and maintaining dermal matrix integrity. This study shows that SH-NPs alleviate DEHP-aggravated psoriasis by suppressing local inflammation, keratinocyte hyperproliferation, and collagen degradation, offering a targeted nanostrategy for environmentally exacerbated skin diseases.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 447
H3K27ac-Activated lncRNA-DAPK1-IT1 Aggravated Oxidative Stress Damage Induced by Focal Cerebral Ischemia/Reperfusion via the miR-25-3p/HMGB1 Molecular Axis
Ischemic stroke is a prevalent neurological disorder, characterized by elevated mortality and significant long-term disability. Oxidative stress damage is an important pathological process that occurs after brain ischemia/reperfusion (I/R), in which the long non-coding RNA death-associated protein kinase 1 intronic transcript 1 (DAPK1-IT1) is aberrantly expressed and participates in oxidative stress damage; however, its specific mechanisms of action remain unclear. DAPK1-IT1 and miR-25-3p expression was detected using qRT-PCR in the mouse neuroblastoma N2a cells that received middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation/reperfusion. Functional gain and loss experiments were performed to manipulate DAPK1-IT1, miR-25-3p, and HMGB1 expression. The role of DAPK1-IT1 was assessed both in vivo and in vitro using CCK-8, flow cytometry, and western blotting. The results showed that the levels of DAPK1-IT1, HMGB1, and oxidative stress damage markers were significantly increased, whereas miR-25-3p expression was significantly downregulated. The expression levels of DAPK1-IT1 were positively correlated with ROS production. DAPK1-IT1 and HMGB1 were identified as potential targets of miR-25-3p. Knockdown of DAPK1-IT1 and HMGB1, as well as overexpression of miR-25-3p, is indeed protective and contribute to reducing oxidative stress damage by activating the Nrf2/HO-1 signaling pathway. DAPK1-IT1 overexpression caused oxidative stress damage in N2a cells by downregulating miR-25-3p expression and upregulating HMGB1 expression. Mechanistically, DAPK1-IT1 upregulated HMGB1 expression by sponging miR-25-3p and mediating histone H3 lysine 27 acetylation in the promoter region through the cAMP response element-binding protein-binding protein (CBP). In summary, we found that H3K27 acetylation-induced lncRNA-DAPK1-IT1 promotes oxidative stress damage caused by I/R through the miR-25-3p/HMGB1 axis. These findings help to improve our understanding of ischemic stroke and provide new therapeutic avenues.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 447
H3K27ac-Activated lncRNA-DAPK1-IT1 Aggravated Oxidative Stress Damage Induced by Focal Cerebral Ischemia/Reperfusion via the miR-25-3p/HMGB1 Molecular Axis
Ischemic stroke is a prevalent neurological disorder, characterized by elevated mortality and significant long-term disability. Oxidative stress damage is an important pathological process that occurs after brain ischemia/reperfusion (I/R), in which the long non-coding RNA death-associated protein kinase 1 intronic transcript 1 (DAPK1-IT1) is aberrantly expressed and participates in oxidative stress damage; however, its specific mechanisms of action remain unclear. DAPK1-IT1 and miR-25-3p expression was detected using qRT-PCR in the mouse neuroblastoma N2a cells that received middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation/reperfusion. Functional gain and loss experiments were performed to manipulate DAPK1-IT1, miR-25-3p, and HMGB1 expression. The role of DAPK1-IT1 was assessed both in vivo and in vitro using CCK-8, flow cytometry, and western blotting. The results showed that the levels of DAPK1-IT1, HMGB1, and oxidative stress damage markers were significantly increased, whereas miR-25-3p expression was significantly downregulated. The expression levels of DAPK1-IT1 were positively correlated with ROS production. DAPK1-IT1 and HMGB1 were identified as potential targets of miR-25-3p. Knockdown of DAPK1-IT1 and HMGB1, as well as overexpression of miR-25-3p, is indeed protective and contribute to reducing oxidative stress damage by activating the Nrf2/HO-1 signaling pathway. DAPK1-IT1 overexpression caused oxidative stress damage in N2a cells by downregulating miR-25-3p expression and upregulating HMGB1 expression. Mechanistically, DAPK1-IT1 upregulated HMGB1 expression by sponging miR-25-3p and mediating histone H3 lysine 27 acetylation in the promoter region through the cAMP response element-binding protein-binding protein (CBP). In summary, we found that H3K27 acetylation-induced lncRNA-DAPK1-IT1 promotes oxidative stress damage caused by I/R through the miR-25-3p/HMGB1 axis. These findings help to improve our understanding of ischemic stroke and provide new therapeutic avenues.